Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Jaguar Health, Inc. (JAGX)

Compare
4.7600
+0.0100
+(0.21%)
At close: April 1 at 4:00:00 PM EDT
4.8500
+0.09
+(1.89%)
After hours: April 1 at 7:52:09 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
10,480
--
11,956
4,335
9,385
Cost of Revenue
2,085
--
2,019
2,333
3,280
Gross Profit
8,395
--
9,937
2,002
6,105
Operating Expense
38,255
--
44,352
41,076
27,409
Operating Income
-29,860
--
-34,415
-39,074
-21,304
Net Non Operating Interest Income Expense
-589
--
-12,723
-10,055
-8,135
Other Income Expense
-7,877
--
-1,257
-3,471
-4,370
Pretax Income
-38,326
--
-48,395
-52,600
-33,809
Net Income Common Stockholders
-37,742
--
-47,454
-52,595
-38,648
Diluted NI Available to Com Stockholders
-37,742
--
-47,454
-52,595
-38,648
Basic EPS
20.20
-107.40
-2.17k
-5.16k
-13.50k
Diluted EPS
20.20
-107.40
-2.17k
-5.16k
-13.50k
Basic Average Shares
4,589.2720
384.4730
21.8580
10.1900
2.8620
Diluted Average Shares
4,589.2720
384.4730
21.8580
10.1900
2.8620
Total Operating Income as Reported
-30,231
--
-34,415
-40,708
-26,647
Rent Expense Supplemental
911
--
629
282
690
Total Expenses
40,340
--
46,371
43,409
30,689
Net Income from Continuing & Discontinued Operation
-37,742
--
-47,454
-52,595
-33,809
Normalized Income
-29,936
--
-45,247
-49,889
-29,249
Interest Expense
8,768
--
12,723
8,421
2,792
Net Interest Income
-589
--
-12,723
-10,055
-8,135
EBIT
-31,459
--
-35,672
-44,179
-31,017
EBITDA
-29,103
--
-33,380
-42,366
-28,737
Reconciled Cost of Revenue
2,085
--
2,019
2,333
3,280
Reconciled Depreciation
2,356
--
2,292
1,813
2,280
Net Income from Continuing Operation Net Minority Interest
-37,742
--
-47,454
-52,595
-33,809
Total Unusual Items Excluding Goodwill
-7,806
--
-2,207
-2,706
-4,560
Total Unusual Items
-7,806
--
-2,207
-2,706
-4,560
Normalized EBITDA
-21,297
--
-31,173
-39,660
-24,177
12/31/2020 - 5/12/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OCGN Ocugen, Inc.
0.6472
-8.37%
 
ADTX Aditxt, Inc.
4.5200
+0.78%
 
CERO CERo Therapeutics Holdings, Inc.
0.7200
-1.37%
 
IBIO iBio, Inc. Common Stock
3.9100
-2.74%
 
VXRT Vaxart, Inc.
0.3725
-8.48%
 
TNXP Tonix Pharmaceuticals Holding Corp.
17.45
-2.38%
 
WINT Windtree Therapeutics, Inc.
1.2000
-4.76%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
 
BDRX Biodexa Pharmaceuticals Plc
1.2000
-9.09%
 
ENSC Ensysce Biosciences, Inc.
2.5000
-2.34%